Evidence for an increased risk of transmission of simian immunodeficiency virus and malaria in a rhesus macaque coinfection model

Journal of Virology

Volumn 85, Issue 22, 2011, Pages 11655-11663

  Trott, Kristin A ^a   Chau, Jennifer Y ^b   Hudgens, Michael G ^c,d   Fine, Jason ^d   Mfalila, Chelu K ^c   Tarara, Ross P ^a   Collins, William E ^e   Sullivan, JoAnn ^e   Luckhart, Shirley ^b   Abel, Kristina ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d IL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DISEASE TRANSMISSION; GAMETOCYTE; IMMUNOSTIMULATION; INFECTION RISK; MALARIA; MALE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYST; OOCYTE DEVELOPMENT; PARASITEMIA; PLASMODIUM; PLASMODIUM FRAGILE; PRIORITY JOURNAL; RHESUS MACAQUE; RHESUS MONKEY; RISK ASSESSMENT; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VIREMIA;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MACACA MULATTA; MALARIA; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIMATE DISEASES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM FALCIPARUM; PLASMODIUM FRAGILE; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 80655146246     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05644-11     Document Type: Article

References (52)

1. Abel, K., et al. 2006. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses. J. Virol. 80:6357-6367.
2. Abel, K., D. M. Rocke, B. Chohan, L. Fritts, and C. J. Miller. 2005. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J. Virol. 79:12164-12172.
3. Abu-Raddad, L. J., P. Patnaik, and J. G. Kublin. 2006. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 314:1603-1606.
4. Aikawa, M., et al. 1992. Plasmodium coatneyi-infected rhesus monkeys: a primate model for human cerebral malaria. Mem. Inst. Oswaldo Cruz 87(Suppl. 3):443-447.
5. Ariyoshi, K., M. Schim van der Loeff, N. Berry, S. Jaffar, and H. Whittle. 1999. Plasma HIV viral load in relation to season and to Plasmodium falciparum parasitaemia. AIDS 13:1145-1146.
6. Blond, D., et al. 1998. Nitric oxide synthesis during acute SIVmac251 infection of macaques. Res. Virol. 149:75-86.
7. Brown, K. N., A. Trichel, and S. M. Barratt-Boyes. 2007. Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS. J. Immunol. 178:6958-6967.
8. Chandramohan, D., and B. M. Greenwood. 1998. Is there an interaction between human immunodeficiency virus and Plasmodium falciparum? Int. J. Epidemiol. 27:296-301.
9. Chin, W., D. Moss, and W. E. Collins. 1979. The continuous cultivation of Plasmodium fragile by the method of Trager-Jensen. Am. J. Trop. Med. Hyg. 28:591-592.
10. Cline, A. N., J. W. Bess, M. Piatak, Jr., and J. D. Lifson. 2005. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol. 34:303-312.
11. Coatney, G. R., W. E. Collins, M. Warren, and P. G. Contacos. 1971. The primate malarias. CDC, Division of Parasitic Diseases, Atlanta, GA.
12. Cohen, C., et al. 2005. Increased prevalence of severe malaria in HIVinfected adults in South Africa. Clin. Infect. Dis. 41:1631-1637.
13. Collins, W. E., W. Chin, and J. C. Skinner. 1979. Plasmodium fragile and Macaca mulatta monkeys as a model system for the study of malaria vaccines. Am. J. Trop. Med. Hyg. 28:948-954.
14. Collins, W. E., J. R. Jumper, C. S. Smith, and J. C. Skinner. 1977. The exoerythrocytic stages of Plasmodium fragile in Macaca mulatta monkeys. J. Parasitol. 63:226-231.
15. Collins, W. E., et al. 1994. Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile. Am. J. Trop. Med. Hyg. 51:711-719.
16. Collins, W. E., et al. 2006. Studies on sporozoite-induced and chronic infections with Plasmodium fragile in Macaca mulatta and New World monkeys. J. Parasitol. 92:1019-1026.
17. Donaghy, H., B. Gazzard, F. Gotch, and S. Patterson. 2003. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 101:4505-4511.
18. Drakeley, C., C. Sutherland, J. T. Bousema, R. W. Sauerwein, and G. A. Targett. 2006. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol. 22:424-430.
19. Eyles, D. E. 1950. A stain for malarial oocysts in temporary preparations. J. Parasitol. 36:501.
20. French, N., et al. 2001. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 15:899-906.
21. Fujioka, H., et al. 1994. A nonhuman primate model for human cerebral malaria: rhesus monkeys experimentally infected with Plasmodium fragile. Exp. Parasitol. 78:371-376.
22. Grimwade, K., et al. 2004. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS 18:547-554.
23. Hay, S. I., C. A. Guerra, A. J. Tatem, A. M. Noor, and R. W. Snow. 2004. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect. Dis. 4:327-336.
24. Hoffman, I. F., et al. 1999. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 13:487-494.
25. Hofmann, W., et al. 1999. Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73:10020-10028.
26. Koehler, J. W., et al. 2009. Altered immune responses in rhesus macaques co-infected with SIV and Plasmodium cynomolgi: an animal model for coincident AIDS and relapsing malaria. PLoS One 4:e7139.
27. Korenromp, E. L., et al. 2005. Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg. Infect. Dis. 11:1410-1419.
28. Kublin, J. G., et al. 2005. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 365:233-240.
29. Ljungstrom, I., H. Perlmann, M. Schlichtherle, A. Schert, and M. Wahlgren. 2004. Methods in malaria research, 4th ed. Malaria Research and Reference Reagent Resource Center/ATCC, Manassas, VA.
30. Marthas, M. L., et al. 2011. Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques. Vaccine 29:3124-3137.
31. Millington, O. R., C. Di Lorenzo, R. S. Phillips, P. Garside, and J. M. Brewer. 2006. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J. Biol. 5:5.
32. Mount, A. M., et al. 2004. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 363:1860-1867.
33. Nacher, M., et al. 2002. Decreased hemoglobin concentrations, hyperparasitemia, and severe malaria are associated with increased Plasmodium falciparum gametocyte carriage. J. Parasitol. 88:97-101.
34. Owens, C. M., P. C. Yang, H. Gottlinger, and J. Sodroski. 2003. Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J. Virol. 77:726-731.
35. Parker, R. A., M. M. Regan, and K. A. Reimann. 2001. Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics. J. Virol. 75:11234-11238.
36. Petrovas, C., et al. 2007. SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110:928-936.
37. Qari, S. H., Y. P. Shi, N. J. Pieniazek, W. E. Collins, and A. A. Lal. 1996. Phylogenetic relationship among the malaria parasites based on small subunit rRNA gene sequences: monophyletic nature of the human malaria parasite, Plasmodium falciparum. Mol. Phylogenet. Evol. 6:157-165.
38. Schneider, P., et al. 2005. Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum. J. Clin. Microbiol. 43:402-405.
39. Torre, D., and G. Ferrario. 1996. Immunological aspects of nitric oxide in HIV-1 infection. Med. Hypotheses 47:405-407.
40. Torre, D., A. Pugliese, and F. Speranza. 2002. Role of nitric oxide in HIV-1 infection: friend or foe? Lancet Infect. Dis. 2:273-280.
41. Trager, W., and G. S. Gill. 1992. Enhanced gametocyte formation in young erythrocytes by Plasmodium falciparum in vitro. J. Protozool. 39:429-432.
42. Trager, W., G. S. Gill, C. Lawrence, and R. L. Nagel. 1999. Plasmodium falciparum: enhanced gametocyte formation in vitro in reticulocyte-rich blood. Exp. Parasitol. 91:115-118.
43. Tripathi, R., R. A. Vishwakarma, and G. P. Dutta. 1997. Plasmodium fragile: efficacy of arteether (alpha/beta) against cerebral malaria model. Exp. Parasitol. 87:290-292.
44. UNAIDS. 2008. AIDS epidemic update, December 2008. UNAIDS/WHO, Geneva, Switzerland. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/.
45. Urban, B. C., et al. 1999. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400:73-77.
46. Van Geertruyden, J. P., J. Menten, R. Colebunders, E. Korenromp, and U. D'Alessandro. 2008. The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance. Malar. J. 7:134.
47. Van Geertruyden, J. P., et al. 2009. Impact of HIV-1 infection on the hematological recovery after clinical malaria. J. Acquir. Immune Defic. Syndr. 50:200-205.
48. Van Rompay, K. K., et al. 2010. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV. Vaccine 28:1481-1492.
49. Waters, A. P., D. G. Higgins, and T. F. McCutchan. 1993. Evolutionary relatedness of some primate models of Plasmodium. Mol. Biol. Evol. 10: 914-923.
50. Whitworth, J., et al. 2000. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 356:1051-1056.
51. Xiao, L., S. M. Owen, D. L. Rudolph, R. B. Lal, and A. A. Lal. 1998. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J. Infect. Dis. 177:437-445.
52. Zapata, J. C., et al. 2002. Reproducible infection of intact Aotus lemurinus griseimembra monkeys by Plasmodium falciparum sporozoite inoculation. J. Parasitol. 88:723-729.